Asthma Ascertainment and Characterization through Electronic Health Records

Overview

Información sobre este estudio

The purpose of this study is to look to see if automated chart review by computer predicts asthma status and asthma status characterization.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

Mayo Site

  • Children born in Olmsted County between 1997–2016. with age of 3-26 years old.
  • Research authorization for using medical record for research.
  • Children who have received medical care at only Mayo Clinic.

Sanford Children's Hospital (for Aim 4 only)

  • Children who were born between November 1, 2011, and December 31, 2018.

Exclusion Criteria: 

  • No research authorization for using medical record for research.*
  • Non-Olmsted County residents defined by non-Olmsted County address in medical record within one year prior to last follow-up date as of data abstraction.*
  • Insufficient medical record to ascertain asthma status or other variables.
  • Children who left the community before the age of 3 years because API requires medical history at least during the first 3 years of life.*
  • Adopted children (lack of information on a family history of parents which is one of API criteria).
  • Conditions making asthma ascertainment difficult (tracheobronchial foreign body at or about the incidence date of asthma, bullous emphysema or pulmonary fibrosis, PiZZ alpha1-antitrypsin, cystic fibrosis, hypogammaglobulinemia (IgG<2.0 mg/mL), other immunodeficiency disorder (or conditions identified by the International Union of Immunological Societies at index date of AIICs), primary ciliary dyskinesia, bronchiectasis, or COPD if it is present) and other major chest disease (severe kyphoscoliosis or bronchiectasis) which will be identified by ICD code and free text search.
  • Immunodeficiency or immunosuppressive therapy:  Patients who had received immunosuppressive or immunoglobulin therapy or transfusion within twelve months prior to index date of AIICs except corticosteroid burst therapy for asthma exacerbation. 
  • Children who weigh below 17 kg (the volume of blood taken from the donors is minimized to be less than 3 mL/kg bodyweight for a venipuncture).*
  • A history of malignancy at index date of AIICs.

* Applied to Mayo site study only.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Young Juhn, M.D., M.P.H.

Cerrado para la inscripción

Contact information:

Julie Porcher

(507) 255-8163

Porcher.Julie@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20308374

Mayo Clinic Footer